advertisement
Journal of Ocular Pharmacology and Therapeutics 13
Showing records 1 to 13 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics48557 Plasma citrate levels as a potential biomarker for glaucoma
Fraenkl SA; Muser J; Groell R; Reinhard G; Orgul S; Flammer J; Goldblum D
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 577-580
48630 Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma
Konstas AG; Quaranta L; Mikropoulos DG; Nasr MB; Russo A; Jaffee HA; Stewart JA; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 26-32
49015 Comparison of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations on Diurnal Intraocular Pressure Control in Primary Open-Angle Glaucoma
Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 381-386
48747 Topiramate induced bilateral angle-closure glaucoma: low dosage in a short time
Caglar C; Yasar T; Ceyhan D
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 205-207
48973 Efficacy of Single Glaucoma Drug in Combined Timolol XE, Latanoprost and Brinzolamide Therapy: A Discontinuation Study
Kobayashi H
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 245-250
48683 The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment
Ayala M; Chen E
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 118-122
48735 Comparison of human ocular distribution of bimatoprost and latanoprost
Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 134-145
48695 In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes
Choi HY; Lee JE; Lee JW; Park HJ; Jung JH
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 146-152
48637 Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%/timolol maleate 0.5% fixed combination
Inoue K; Okayama R; Higa R; Sawada H; Wakakura M; Tomita G
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 581-587
48529 Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study
Pescosolido N; Librando A; Puzzono M; Nebbioso M
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 629-635
48532 A cannabinoid ligand, anandamide, exacerbates endotoxin-induced uveitis in rabbits
Altinsoy A; Dilekö,z E; Kul O; Ilhan SÖ,; Tunccan OG; Seven I; Bagriacik EU; Sarioglu Y; Or M; Ercan ZS
Journal of Ocular Pharmacology and Therapeutics 2011; 27: 545-552
49016 New Mucoadhesive Chitosan Film for Ophthalmic Drug Delivery of Timolol Maleate: In Vivo Evaluation
Fulgê,ncio GD; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Jú,nior AD
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 350-358
48684 Upregulation of Low-Density Lipoprotein Receptor After Exposure to Transforming Growth Factor-β(2) in Tenon's Capsule Fibroblasts from Patients with Glaucoma
Li X; Zhang W; Shao T; Ma J; Huang L; Gao Q; Ge J
Journal of Ocular Pharmacology and Therapeutics 2012; 28: 179-185
